CD274 and neoplasm: Recently, an immunoscore including the expression of PD-L1+ immune cells in the stromal compartment and PD-L1+ intraepithelial tumor-infiltrating lymphocytes was proposed as independent positive prognostic factors for NSCLC patients [21].